Biopharma

Opinion: The NIH’s drastic cut to indirect cost rates i...

The drastic reduction in indirect costs is not a path to innovation or cost savi...

STAT+: NIH plans to slash support for indirect research...

The NIH said Friday night that it would slash support for indirect costs on all ...

NIH scraps program to diversify the biomedical workforc...

Applications for a prestigious NIH grant that supports Ph.D. students from margi...

Trump administration allows some global aid to restart,...

The Trump administration on Friday said global malaria aid can restart, but it w...

STAT+: Hospitals could be Congress’ next target as GOP ...

Republicans are looking for ways to pay for the cost of extending the tax cuts, ...

STAT+: Up and down the ladder: The latest comings and g...

From new hires to departures, promotions and transfers, here are the latest comi...

STAT+: Experts fear disruptions at FDA as Trump offers ...

The FDA is always trying to staff up, and already struggles to fulfill some duties.

Lilly expands GLP-1 research to hypertension, neuro con...

Morning. Today, we have a look at the White House's reported plans to make major...

STAT+: Pharmalittle: We’re reading about a Hims Super B...

Lawmakers want the FDA to review whether a Super Bowl ad from Hims & Hers runs a...

Signs of life at the CDC

Get your daily dose of health and medicine every weekday with STAT’s free newsle...

STAT+: Lawmakers ask FDA to review Hims’ Super Bowl ad ...

Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they sa...

Opinion: STAT+: We need a universal approach to sharing...

The field of life sciences has a drawer/freezer/cryostorage problem.

Q&A: New York’s plan for boosting life expectancy, neig...

Life expectancy in New York City has been falling. A new plan to address it incl...

STAT+: Class action suit over UnitedHealth’s AI care de...

A ruling may come this month on UnitedHealth's motion to dismiss a lawsuit stemm...

Researchers ‘stunned’ after HHMI abruptly cancels progr...

The Howard Hughes Medical Institute abruptly ended a $60 million program to impr...

Crisis in CRISPR world, RFK Jr.’s promises, and a novel...

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if...

STAT+: What to know about MAHA as RFK Jr. nears powerfu...

This week in health care policy and politics: Analyzing MAHA, the White House's ...

PSUSA/00003148/202405

PSUSA/00003148/202405

AI-developed drug will be in trials by year-end, says G...

Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or...

China investigates generic drugs over safety concerns

Anaesthetics are not putting patients to sleep, doctors warn, in call for greate...

Drugmakers warn NHS clawback tax is putting UK at a dis...

Pharma groups say higher levy will stifle growth of life sciences

Robert Kennedy beats back anti-vax label in testy US Se...

Panel grills Donald Trump’s nominee for top health post on abortion stance and ‘...

The big haul

Putting the “loco” in relocation

AstraZeneca ditches plan to build £450mn UK vaccine plant

Decision is a blow to Starmer’s government after setting out pro-growth pitch to...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.